8
Memorial Sloan Kettering Cancer Center is pleased to announce CONTEMPORARY MANAGEMENT OF COMPLEX SKIN CANCERS NOVEMBER 3-4, 2017 Rockefeller Research Laboratories 430 East 67th Street New York, NY 10065

CONTEMPORARY MANAGEMENT OF COMPLEX SKIN CANCERS · medical and surgical management and radiation therapy. Complex skin cancer cases will be presented and discussed in a tumor board

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Memorial Sloan Kettering Cancer Center is pleased to announce

CONTEMPORARY MANAGEMENT OF

COMPLEX SKIN CANCERSNOVEMBER 3-4, 2017Rockefeller Research Laboratories430 East 67th StreetNew York, NY 10065

COURSE OVERVIEW

The purpose of this course is to provide the attendee with a multidisciplinary management approach for patients with skin cancer, including basal cell carcinoma, squamous cell carcinoma, merkel cell carcinoma, melanoma and other complex skin cancers. The topics will focus on advances in epidemiology, pathology and imaging, medical and surgical management and radiation therapy. Complex skin cancer cases will be presented and discussed in a tumor board style with a multidisciplinary panel of experts.

TARGET AUDIENCE

The target audience includes physicians and allied health professionals, who care for patients with skin cancer, including dermatologists, surgical and medical oncologists, otolaryngologists, ophthalmologists, general surgeons, plastic surgeons, pathologists and radiation oncologists.

EDUCATIONAL OBJECTIVES

• Describe melanoma and non melanoma skin cancer incidence and behavior.

• Define factors contributing to behavior and outcome of skin cancers.

• Define characteristics of skin cancers that require aggressive treatment.

• Understand benefits, limitations, and integration of different modalities used in the treatment of skin cancers.

• Review novel approaches to optimize surgical treatment of skin cancers.

• Assess role and variety of radiotherapeutic approaches to complex skin cancers.

• Review role of biological therapy in the treatment of advanced skin cancers.

• Examine the optimal approaches toward reconstruction of defects resulting from resection of skin cancers.

MSK COURSE DIRECTORS

MSK FACULTYRobert J. Allen, Jr., MDAssistant AttendingPlastics and Reconstructive ServiceDepartment of Surgery

Charlotte Ariyan, MD, PhDAssociate Attending SurgeonGastric and Mixed Tumor ServiceDivision of General Surgical Oncology

Christopher Barker, MDAssistant Attending Radiation OncologistDepartment of Radiation Oncology

Klaus J. Busam, MDDirector of DermatopathologyDepartment of Pathology

Chih-Shan Jason Chen, MD, PhDAttending PhysicianDirector of Dermatologic SurgeryHauppaugue Dermatology Section

Daniel Coit, MDAttending SurgeonGastric and Mixed Tumor ServiceDivision of General Surgical Oncology

Sandra D’Angelo, MDAssistant AttendingSarcoma Medical Oncology Service

Lara Dunn, MDAssistant AttendingHead and Neck Oncology ServiceDepartment of Medicine

Alan Ho, MD, PhDAssistant Attending PhysicianHead and Neck ServiceDivision of Solid Tumor OncologyDepartment of Medicine

Travis Hollmann, MD, PhDAttending PathologistSurgical Pathology ServiceDepartment of Pathology

Erica Lee. MDAssistant Attending PhysicianDermatology ServiceDepartment of Medicine

Cecilia Lezcano, MDPathologistDepartment of Pathology

Vanessa Marcell, MS, CGCSenior Genetic Counselor Clinical Genetics Service

Alina Markova, MDAssistant AttendingDermatology ServiceDepartment of Medicine

Evan Matros, MDAssociate Attending SurgeonPlastic and Reconstructive ServiceDepartment of Surgery

Snehal Patel, MDAttending SurgeonHead and Neck ServiceDepartment of Surgery

Tatyana Petukhova, MDFellowDermatology Service

Melissa Pulitzer, MDAttending PathologistSurgical Pathology serviceDepartment of Pathology

Nadeem Riaz, MDRadiation OncologistAssociate Director of Genomics Operations, Immunogenomics and Precision Oncology PlatformRadiation Oncology Service

Benjamin Roman, MDAssistant AttendingHead and Neck ServiceDepartment of Surgery

Anthony Rossi, MDAssistant Attending PhysicianDermatology serviceDepartment of Medicine

Alex Shoushtari, MDAssistant AttendingSolid Tumor Oncology DivisionMelanoma and Immunotherapeutics ServiceDepartment of Medicine

Hilda Stambuk, MDAttending RadiologistNeuroradiology ServiceDepartment of Radiology

Kishwer S. Nehal, MDDirector, Mohs Micrographic and Dermatologic SurgeryDermatology Service

Bhuvanesh Singh, MD, PhDDirector, Laboratory of Epithelial Cancer BiologyHead and Neck Service, Department of Surgery

INVITED FACULTY

Elaine Fuchs, PhDInvestigator, Howard Hughes Medical InstituteRebecca C. Lancefield ProfessorRobin Chemers Neustein Laboratory of Mammalian Cell Biology and Development,The Rockefeller University

Richard Scolyer, MBBS, MDSenior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred HospitalClinical Professor, Discipline of Pathology, Central Clinical School, Sydney Medical School, The University of SydneyCo-Medical Director, Melanoma Institute Australia

DAY 1 Friday, Nov 3, 2017

7:30 am BREAKFAST & REGISTRATION

8:00 am Introductory Remarks Bhuvanesh Singh, MD, PhD Kishwer S. Nehal, MD

BASAL CELL CARCINOMA MODERATOR: Kishwer S. Nehal, MD

8:10 am High Risk BCC & Role of Comorbidity and Quality of Life in Decision Making

Erica Lee, MD

8:25 am Practical Reconstruction Pearls Evan Matros, MD

8:40 am Optical Imaging of BCC: Beyond Diagnosis

Chih-Shan Jason Chen, MD, PhD

8:55 am Basics of Radiographic Imaging for Head & Neck Skin Cancer Hilda Stambuk, MD

9:10 am Radiotherapy as an Alternative to Surgery

Christopher Barker, MD

9:25 am Update on Targeted Therapies Alan Ho, MD, PhD

TUMOR BOARD - BCC Travis Hollmann, MD, PhD and All Faculty

9:40 am Multidisciplinary Challenging Cases – Audience Response Session Q&A

10:40 am BREAK

SYNDROMES & SKIN CANCER MODERATOR: Klaus J. Busam, MD

11:00 am More Than Skin Deep: Hereditary Syndromes Associated with Skin Cancer Alina Markova, MD

11:30 am Pathology of Syndrome-Associated Adnexal Tumors Cecilia Lezcano, MD

11:50 am Decoding the Genetic Counselor’s Role in Hereditary Syndromes Involving Skin Cancer

Vanessa Marcell, MS, CGC

12:05 pm Multidisciplinary Challenging Cases – Q&A

12:30 pm LUNCH

SCIENTIFIC AGENDA

SQUAMOUS CELL CARCINOMA MODERATOR: Bhuvanesh Singh, MD, PhD

1:45 pm Molecular Pathogenesis of SCC of the Skin Elaine Fuchs, PhD

2:05 pm SCC of the Skin — Classification and Clinically Relevant Pathology

Richard Scolyer, MBBS, MD

2:25 pm Approach to Management of SCC in “Danger Areas” of the Head and Neck Region

Snehal Patel, MD

2:40 pm When and How to Assess and Manage Metastasis from SCC to Regional Nodes

Bhuvanesh Singh, MD, PhD

3:00 pm Role of Radiation Therapy Christopher Barker, MD

3:15 pm Novel Systemic Treatments Lara Dunn, MD

TUMOR BOARD - SCC Benjamin Roman, MD and All Faculty

3:30 pm Multidisciplinary Challenging Cases – Audience Response Session Q&A

4:30 pm DAY 1 ADJOURN

DAY 2 Saturday, Nov 4, 2017

8:00 am BREAKFAST

MERKEL CELL CARCINOMA MODERATOR: Christopher Barker, MD

8:30 am Merkel Cell Carcinoma Pathology Melissa Pulitzer, MD

8:45 am Genomics of MCC and Implication for Clinical Targeting Nadeem Riaz, MD

9:00 am Radiation Therapy in the Treatment of MCC Christopher Barker, MD

9:15 am Systemic Treatment Options Sandra D’Angelo, MD

TUMOR BOARD – MCC All Faculty

9:30 am Multidisciplinary Challenging Cases – Audience Response Session Q&A

10:30 am BREAK

LENTIGO MALIGNA MELANOMA MODERATOR: Klaus J. Busam, MD

10:45 am Challenges in Surgical Management Kishwer S. Nehal, MD

11:00 am Lentigo Maligna Melanoma Pathology Richard Scolyer, MBBS, MD

11:15 am Putting It Back Together: The Reconstructive Ladder Robert J. Allen, Jr., MD

11:30 am Role of Imiquimod & Confocal Imaging Anthony Rossi, MD

TUMOR BOARD – LMM All Faculty

11:45 am Multidisciplinary Challenging Cases – Audience Response Session Q&A

12:30 pm LUNCH

SCIENTIFIC AGENDA

MELANOMA MODERATOR: Charlotte E. Ariyan, MD, PhD

1:30 pm AJCC 8th Edition Melanoma Staging Updates and Melanoma Genetics Richard Scolyer, MBBS, MD

2:00 pm Evolution in Management of Nodal Disease Daniel Coit, MD

2:20 pm Pathologic Assessment and Reporting of Margins

Klaus J Busam, MD

2:35 pm Adjuvant Surgery Charlotte Ariyan, MD, PhD

2:55 pm Management of Advanced Disease Alexander Shoushtari, MD

TUMOR BOARD – MELANOMA All Faculty

3:15 pm Multidisciplinary Challenging Cases – Audience Response Session Q&A

4:15 pm CLOSING REMARKS & SYMPOSIUM ADJOURN

Registration includes continental breakfast, lunch and refreshment breaks. Please contact us at least one week prior to the course if you have any special dietary needs.

30% Discounted Rate for MSK Alumni and MSK Alliance Members MSK offers a 30% discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact [email protected] for a promo code or more information.

MSK Staff Registration Registration is complimentary for MSK staff who wish to attend this course. However, you must register online by visiting the course website: www.mskcc.org/skincancercourse

ACCREDITATION STATEMENTMSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTMSK designates this live activity for a maximum of 13.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The AMA has determined that physiciansnot licensed in the United States but who participate in thisCME activity are eligible for 13.50 AMA PRA Category 1 Credits™.

FACULTY DISCLOSURE It is the policy of MSK to make every effort to insure balance, independence, objectivity and scientific rigor in all continuing medical education activities which it sponsors as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity sponsored by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational

ACCOMMODATIONSFor travel information, including hotels in the area of MSK with discounted rates, please visit: www.mskcc.org/cme.

EARLYBEFORE 9/8/17

GENERALAFTER 9/8/17

Physicians (MDs, PhDs, DOs) $400 $450

Fellows, Residents, Nurses, Other Health Care Providers $100 $150

Industry* $785 $785

Register online at: www.mskcc.org/SkinCancerCourse

REGISTRATION

CONTINUING MEDICAL EDUCATIONMEMORIAL SLOAN KETTERING CANCER CENTER

633 Third Avenue, 12th Floor, New York, NY 10017www.mskcc.org/cme | [email protected]

/MSKCME @MSKCME MSK CME LinkedIn Group